Cas:102036-28-2 Protosappanin A manufacturer & supplier

We serve Chemical Name:Protosappanin A CAS:102036-28-2 to global customers since 2007, Pls send inquiry to info@nbinno.com or visit www.nbinno.com our official website should you have any interests. This site is for information only.

Protosappanin A

Chemical Name:Protosappanin A
CAS.NO:102036-28-2
Synonyms:6H-Dibenz(b,d)oxocin-7(8H)-one,3,10,11-trihydroxy;3,10,11-Trihydroxy-6H-dibenzo[b,d]oxocin-7(8H)-one;Sappanol B;6H-Dibenz(b,d)oxocin-7(8H)-one, 3,10,11-trihydroxy-;6H-Dibenz[b,d]oxocin-7(8H)-one, 3,10,11-trihydroxy-
Molecular Formula:C15H12O5
Molecular Weight:272.25
HS Code:

Physical and Chemical Properties:
Melting point:N/A
Boiling point:613.1±55.0 °C at 760 mmHg
Density:1.5±0.1 g/cm3
Index of Refraction:1.689
PSA:86.99000
Exact Mass:272.068481
LogP:1.20

Material Safety Information (Applicable for Hazard Chemicals)
RIDADR:
Packing Group:


Contact us for information like 6H-Dibenz(b,d)oxocin-7(8H)-one,3,10,11-trihydroxy chemical properties,Structure,melting point,boiling point,density,molecular formula,molecular weight,6H-Dibenz[b,d]oxocin-7(8H)-one, 3,10,11-trihydroxy- physical properties,toxicity information,customs codes,safety, risk, hazard and MSDS, CAS,cas number,Sappanol B Use and application,6H-Dibenz(b,d)oxocin-7(8H)-one,3,10,11-trihydroxy technical grade,usp/ep/jp grade.


Related News: As Reuters reported last month, Lilly tapped the Washington D.C. law firm Covington & Burling LLP to investigate the alleged alterations, which the employees said were meant to downplay serious quality control problems at the plant producing the drugmaker’s COVID-19 antibody treatment. Protosappanin A manufacturer The agency’s first recommendation was straightforward: “Stop using the Innova SARS-CoV-2 Antigen Rapid Qualitative Test. Destroy the tests by placing them in the trash or return the tests to Innova using the FedEx return label that was included with the recall letter that Innova sent to customers.” Protosappanin A supplier As Reuters reported last month, Lilly tapped the Washington D.C. law firm Covington & Burling LLP to investigate the alleged alterations, which the employees said were meant to downplay serious quality control problems at the plant producing the drugmaker’s COVID-19 antibody treatment. Protosappanin A vendor According to statistics from the Price Supervision and Competition Bureau of the National Development and Reform Commission, China can produce more than 1,500 kinds of bulk drugs, with a total output of one million tons and an export volume of more than 60%. It has become the world’s second largest drug substance after the United States. Country of manufacture and largest exporter. Protosappanin A factory We manufacture APIs and drug manufacturers make medicines from APIs.